16 parallel-processing-bioinformatics-"Multiple" PhD positions at Trinity College Dublin
Sort by
Refine Your Search
-
risk. These studentships are ideal for candidates with a strong background in computational biology, bioinformatics, population genetics, and statistical genetics and an exceptional interest in
-
from multiple high-income countries, including the UK (UKHLS), Germany (SOEP), Australia (HILDA), and the US (PSID), alongside ageing studies such as SHARE, ELSA, and TILDA. Where feasible
-
landscape of Alzheimer's Disease-Modifying Therapies (DMTs). The research will examine multiple dimensions of system readiness through an interdisciplinary lens - from diagnostic pathways and workforce
-
”. Application Procedure Informal enquiries are very welcome and can be made directly to Dr Tim Bodt (tim.bodt@tcd.ie), Associate Professor, School of Linguistic, Speech and Communication Sciences. To apply
-
tinnitus compared to other treatments. Application Procedure Applicants should submit a full Curriculum Vitae to include the names and contact details of 2 referees (including email addresses), to:- Name
-
that honours the complexity of the forced displacement process. Applicants are asked to submit a research statement that demonstrates how their research background and skills match with the project, and how
-
such as scRNA-seq, bulk RNA-seq, DNAm analysis, proteomics and clinical data integration to determine how IFN-I responses change during ageing. Application Procedure Applicants should submit a cover letter
-
modelling. Application Procedure Applicants should submit a full Curriculum Vitae to include the names and contact details of 2 referees (including email addresses), to:- Name: Dr. David Igoe Email Address
-
. Application Procedure Applicants should submit a full Curriculum Vitae to include the names and contact details of 2 referees (including email addresses), to:- Name: Dr. David Igoe Email Address: igoed@tcd.ie
-
. As exposure to these risk factors begins 20-40 years before dementia onset, interventions must be implemented in mid-life. However, the indicators of the disease process in mid-life are poorly